Burning Rock Dx hold B round the signing ceremony, officially announced that they had obtained total RMB 300 million of B round. Investors including Sequoia capital, Economic capital, ZhaoYin internation and the star of lenovo. This is another round of wholesale funding stepd the August 14, 2015, A + wheel 150 million yuan .

Since established in March 2014, Burning Rock Dx focused on for tumor patients and the risk of tumor population genetic testing services and medication guide. According to the different characteristics of solid tumor molecular classification, Burning Rock Dx research and develop independently targeted medication guide genetic testing products. Series is designed for multiple cancer types of these products, respectively to detect the cancer gene corresponding to key groups, thus looking for targeted therapy for patients with critical information. Burning Rock Dx obtained the approval for establishment of for-profit medical professional institutions in March 2015 . Only half a year of promotion, Burning Rock Dx has an extensive cooperation with domestic provinces 3 armour hospital, test sample quantity rapid growth

Burning Rock Dx won 43 million yuan in 2014 of A round of funding (by the school and lenovo star investment), and in August 2015 peak, sequoia capital obtained by dhi, lenovo star tripartite investment institutions of RMB 150 million A + round of funding. The current 300 million yuan B round of funding will provide the necessary funds for the further development of Burning Rock Dx.